Related Experiment Video
Updated: Jun 7, 2025

06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.1K
Perimenopausal combined hormonal contraception: focus on sexual function
1Obstetrics and Gynecology Department, Marmara University School of Medicine, Istanbul, Turkey.
Climacteric : the Journal of the International Menopause Society
|November 13, 2024
Summary
Women in their 40s can use combined hormonal contraception (CHC) until age 50 if medically eligible. Counseling on benefits, risks, and multifactorial causes of sexual dysfunction is crucial.
Area of Science:
- Reproductive Health
- Contraception
- Sexual Health
Background:
- Age is not an absolute contraindication for contraceptive methods.
- Medical eligibility criteria are essential for combined hormonal contraception (CHC) selection.
- Women in their 40s require counseling on CHC benefits and risks.
Purpose of the Study:
- To review the use of combined hormonal contraception (CHC) in women aged 40 and above.
- To discuss the multifactorial nature of libido loss and sexual dysfunction in this age group.
- To provide guidance on managing suspected CHC-related sexual dysfunction.
Main Methods:
- Review of current medical eligibility criteria for CHC use.
- Discussion of factors influencing female sexual function in the late 40s.
- Outline of assessment and management strategies for sexual dysfunction.
Main Results:
- Women can use CHC until age 50 if no contraindications exist.
- Libido loss and urogenital issues are common but multifactorial.
- Comprehensive assessment is needed before attributing sexual dysfunction to CHC.
Conclusions:
- CHC is a viable contraceptive option for women in their 40s, up to age 50, provided medical eligibility is met.
- Sexual dysfunction in this age group is complex and requires thorough biopsychosocial evaluation.
- Management of suspected CHC-related sexual dysfunction involves adjusting the contraceptive method or dose.
More Related Videos
Related Concept Videos
Menopause
140
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
140
Hormonal Regulation of the Menstrual Cycle
297
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
297
Hormonal Control of the Ovarian Cycle
418
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
418
Birth Control Methods
200
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
200
Hormonal Regulation
43.2K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.2K
Gonadal and Placental Hormones
1.3K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
1.3K

